Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96954417 | 9695441 | 7 | F | 201310 | 20160825 | 20131119 | 20160830 | EXP | PHHY2013FR131701 | NOVARTIS | 55.00 | YR | M | Y | 0.00000 | 20160830 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96954417 | 9695441 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD (28 TABLETS) | 22334 | 10 | MG | QD | |||||||
| 96954417 | 9695441 | 2 | C | MEDROL | METHYLPREDNISOLONE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | TABLET | QD | ||||||
| 96954417 | 9695441 | 3 | C | OXYNORM | OXYCODONE HYDROCHLORIDE | 1 | Oral | 10 MG, BID | 0 | 10 | MG | BID | |||||||
| 96954417 | 9695441 | 4 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 90 MG, BID | 0 | 90 | MG | BID | |||||||
| 96954417 | 9695441 | 5 | C | MACROGOL | POLYETHYLENE GLYCOLS | 1 | Oral | 5.9 G, QID | 0 | 5.9 | G | QID | |||||||
| 96954417 | 9695441 | 6 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0.4 ML, QD | 0 | .4 | ML | INJECTION | QD | ||||||
| 96954417 | 9695441 | 7 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Oral | 600 MG, BID | 0 | 600 | MG | BID | |||||||
| 96954417 | 9695441 | 8 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 96954417 | 9695441 | 9 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 1 G, QID | 0 | 1 | G | QID | |||||||
| 96954417 | 9695441 | 10 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 96954417 | 9695441 | 11 | C | ALPRESS | PRAZOSIN | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 96954417 | 9695441 | 12 | C | LYRICA | PREGABALIN | 1 | Oral | 75 MG, BID | 0 | 75 | MG | BID | |||||||
| 96954417 | 9695441 | 13 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | QD | |||||||
| 96954417 | 9695441 | 14 | C | INEXIUM//ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 96954417 | 9695441 | 15 | C | BROMAZEPAM | BROMAZEPAM | 1 | Oral | 6 MG, TID | 0 | 6 | MG | TABLET | TID | ||||||
| 96954417 | 9695441 | 16 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96954417 | 9695441 | 1 | Renal cancer |
| 96954417 | 9695441 | 2 | Antiinflammatory therapy |
| 96954417 | 9695441 | 3 | Pain |
| 96954417 | 9695441 | 4 | Pain |
| 96954417 | 9695441 | 5 | Constipation |
| 96954417 | 9695441 | 6 | Coagulopathy |
| 96954417 | 9695441 | 7 | Hypokalaemia |
| 96954417 | 9695441 | 8 | Hypertriglyceridaemia |
| 96954417 | 9695441 | 9 | Pain |
| 96954417 | 9695441 | 10 | Hypertension |
| 96954417 | 9695441 | 11 | Hypertension |
| 96954417 | 9695441 | 12 | Pain |
| 96954417 | 9695441 | 13 | Gastrooesophageal reflux disease |
| 96954417 | 9695441 | 14 | Gastrooesophageal reflux disease |
| 96954417 | 9695441 | 15 | Anxiety |
| 96954417 | 9695441 | 16 | Antiemetic supportive care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96954417 | 9695441 | OT |
| 96954417 | 9695441 | DE |
| 96954417 | 9695441 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96954417 | 9695441 | Confusional state | |
| 96954417 | 9695441 | General physical health deterioration | |
| 96954417 | 9695441 | Hypoxia | |
| 96954417 | 9695441 | Lung disorder | |
| 96954417 | 9695441 | Musculoskeletal chest pain | |
| 96954417 | 9695441 | Nervous system disorder | |
| 96954417 | 9695441 | Pyrexia | |
| 96954417 | 9695441 | Respiratory disorder | |
| 96954417 | 9695441 | Septic shock | |
| 96954417 | 9695441 | Spinal cord compression | |
| 96954417 | 9695441 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96954417 | 9695441 | 1 | 20131002 | 201310 | 0 | |
| 96954417 | 9695441 | 2 | 201307 | 0 | ||
| 96954417 | 9695441 | 3 | 20130506 | 0 | ||
| 96954417 | 9695441 | 4 | 20130410 | 0 | ||
| 96954417 | 9695441 | 5 | 20130410 | 0 | ||
| 96954417 | 9695441 | 6 | 20130410 | 0 | ||
| 96954417 | 9695441 | 7 | 20130410 | 0 | ||
| 96954417 | 9695441 | 8 | 20130410 | 0 | ||
| 96954417 | 9695441 | 9 | 20130327 | 0 | ||
| 96954417 | 9695441 | 10 | 20130327 | 0 | ||
| 96954417 | 9695441 | 11 | 20121115 | 0 | ||
| 96954417 | 9695441 | 12 | 20130327 | 0 | ||
| 96954417 | 9695441 | 13 | 20130327 | 0 | ||
| 96954417 | 9695441 | 14 | 20130327 | 0 | ||
| 96954417 | 9695441 | 15 | 20130327 | 0 | ||
| 96954417 | 9695441 | 16 | 20130301 | 0 |